bristol-myers squibb co (BRM:Frankfurt)
Transactions by BRISTOL-MYERS SQUIBB CO (BRM) in the last 6 months
Allied-Bristol Life Sciences, LLC announced that it has received a round of funding from new investors Allied Minds plc and Bristol-Myers Squibb Company on August 3, 2014. The investors will each acquire 50% stake in the company through this transaction.
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE:BMY) acquired iPierian, Inc. from a group of investors for approximately $730 million on April 29, 2014. As per the deal, Bristol-Myers will pay $175 million at closing and a potential for additional development and regulatory milestone payments totaling $550 million. Group of investors includes ATEL Ventures, Inc., FinTech Global Capital, Highland Capital Partners, Mission Bay Capital LLC, Mitsubishi UFJ Capital Co. Ltd., MPM Capital, ...
Biogen Idec New Ventures, Inc.
FinTech Global Capital
Highland Capital Partners
Kleiner Perkins Caufield & Byers
Mission Bay Capital LLC
Mitsubishi UFJ Capital Co. Ltd.
|AbbVie Inc||$60.29 USD||+0.77|
|AstraZeneca PLC||4,328 GBp||-7.00|
|Biogen Idec Inc||$321.67 USD||+5.61|
|Celgene Corp||$103.24 USD||+2.84|
|Novo Nordisk A/S||kr267.10 DKK||-2.40|
|View Industry Companies|